Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Augmentin for Dog Bite Prophylaxis
NCT00185939Phase 3Completed
- Sponsor
- Stanford University
- Start
- Aug 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Dog bite comparing Augmentin with Placebo (2 arms). Primary endpoint: Wound infection. Started Aug 2003; status: completed.
02
Drugs
amoxicillin + clavulanate
03
Conditions
Dog bite
Beyond the preview
Go deeper on NCT00185939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00185939.